Clinical Trials Logo

Clinical Trial Summary

The number of lung biopsies has increased steadily in recent years. Pneumothorax is the most common complication of a lung biopsy and can occur during the procedure, immediately after the procedure or within a few hours (delayed pneumothorax). The incidence of pneumothorax in the literature is very different from one study to another: it has been reported to be from 9 to 54% in patients undergoing percutaneous transthoracic needle biopsy. This difference of incidence could be explained by the absence of consensus for the definition of an iatrogenic pneumothorax. The characteristics of pneumothorax and the management of patients with iatrogenic pneumothorax will be evaluated in different centres in a retrospective manner. This study will contribute to refining the criteria for defining pneumothorax occurring during lung biopsy and will provide a better understanding of the condition and its management.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05259293
Study type Observational
Source Centre Hospitalier Universitaire de Besancon
Contact Candice HOUG
Phone 0381218341
Email choug@chu-besancon.fr
Status Recruiting
Phase
Start date December 9, 2021
Completion date March 2022

See also
  Status Clinical Trial Phase
Completed NCT02959203 - Comparison of Bedside Ultrasound With Chest X-ray for Confirmation of Central Venous Catheter Position N/A
Withdrawn NCT03669003 - Gelfoam to Prevent Pneumothorax After Lung Biopsy Phase 2